Which statement best describes the GLP Quality Assurance Unit?

Which statement best describes the GLP Quality Assurance Unit?

• A. A regulatory body overseeing nonclinical studies
• B. Any person or organizational element, except the study director, designated to perform the duties relating to quality assurance of nonclinical laboratory studies
• C. The sponsor's quality control manager
• D. The testing facility's auditor who reports to FDA

Answer: (B)

The key idea is independence in quality assurance for GLP studies. The GLP Quality Assurance Unit is an internal function (it can be a person or an organizational element within the testing facility) that is designated to perform quality assurance duties for nonclinical laboratory studies, and it must operate independently of the study conduct. The study director is responsible for how the study is run, so they are not the QA unit. The QA unit’s job is to monitor and verify that studies are planned, conducted, recorded, and reported in compliance with GLP and the facility’s SOPs, through activities like audits of facilities, procedures, records, raw data, and final reports, and by ensuring deviations are properly documented and corrective actions implemented. This independence is why the QA unit is not described as a regulatory body, the sponsor’s quality control manager, or an auditor reporting to the FDA. It remains an internal, objective check within the facility, reporting through appropriate facility management to maintain ongoing GLP compliance.

The key idea is independence in quality assurance for GLP studies. The GLP Quality Assurance Unit is an internal function (it can be a person or an organizational element within the testing facility) that is designated to perform quality assurance duties for nonclinical laboratory studies, and it must operate independently of the study conduct. The study director is responsible for how the study is run, so they are not the QA unit. The QA unit’s job is to monitor and verify that studies are planned, conducted, recorded, and reported in compliance with GLP and the facility’s SOPs, through activities like audits of facilities, procedures, records, raw data, and final reports, and by ensuring deviations are properly documented and corrective actions implemented.

This independence is why the QA unit is not described as a regulatory body, the sponsor’s quality control manager, or an auditor reporting to the FDA. It remains an internal, objective check within the facility, reporting through appropriate facility management to maintain ongoing GLP compliance.